High Activity Of Selective Essential Oils Against Stationary Phase Borrelia burgdorferi As A Persister Model
Lyme disease is a most common vector borne disease in the US. Although the majority of Lyme patients can be cured with the standard 30 day antibiotic treatment, about 10-20% of patients continue to suffer from prolonged post-treatment Lyme disease syndrome (PTLDS). While the cause for this is unclear, one possibility is that persisting organisms are not killed by current Lyme antibiotics. It has been reported in the literature that essential oils have antimicrobial activities and some have been used by patients with persisting symptoms with varying degree of improvement. However, the activity of essential oils on the causative agent Borrelia burgdorferi (B. burgdorferi) has not been studied. Here, we evaluated the activity of a panel of 34 essential oils for activity against B. burgdorferi stationary phase cells. Interestingly, we found that many essential oils had varying degrees of activity against the stationary phase B. burgdorferi. In particular, the top 5 essential oils (oregano, cinnamon bark, clove bud, citronella, and wintergreen) at a low concentration of 0.25% showed more activity than the persister drug daptomycin (40 microM). An interesting observation is that the highly active essential oils were found to have excellent anti-biofilm ability as shown by their ability to dissolve the aggregated biofilm-like structures. In subculture studies, the three top hits, oregano, cinnamon bark and clove bud completely eradicated all viable cells without any regrowth, but citronella, wintergreen, and geranium bourbon could not completely kill the stationary phase B. burgdorferi with many spirochetes being visible after 21-day subculture. In addition, carvacrol was found to be the most active ingredient of oregano oil and had excellent activity against B. burgdorferi stationary phase cells, while p-cymene and alpha-terpinene had no apparent activity. Future studies are needed to further evaluate and optimize the active essential oils and in drug combinations in vitro and in vivo for improved treatment of persistent Lyme disease.
- Downloaded 3,041 times
- Download rankings, all-time:
- Site-wide: 1,655 out of 84,293
- In microbiology: 126 out of 7,175
- Year to date:
- Site-wide: 10,759 out of 84,293
- Since beginning of last month:
- Site-wide: 9,618 out of 84,293
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!